Safety assessment of gadobenate dimeglumine (MultiHance): extended clinical experience from phase I studies to post-marketing surveillance.
about
Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practiceLower-extremity wounds. 1: Vascular disease assessment.Is administration of gadolinium-based contrast media to pregnant women and small children justified?Pulmonary embolism: comparison of angiography with spiral computed tomography, magnetic resonance angiography, and real-time magnetic resonance imaging.Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation.Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children.
P2860
Q30583956-526695A9-DBD3-4152-9EC6-0F8CD15F231EQ33847006-B445A8C9-11AE-4671-8BE7-A677B4EA50DDQ33873443-47F739EE-7FBD-4FC6-8B21-DCF7FE565A28Q35215268-6CB82410-C1D9-4705-99B0-C903C718D6C4Q37934729-D3741C48-A687-4316-8A69-980D950C8CF7Q39636242-FD561179-115C-4539-B064-920D1836B3B4Q43825978-5F4E2728-674F-43F8-9A94-5B264161580CQ48280965-ADE6EDE3-6376-4DC3-BD14-1C766BA94639
P2860
Safety assessment of gadobenate dimeglumine (MultiHance): extended clinical experience from phase I studies to post-marketing surveillance.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Safety assessment of gadobenat ...... o post-marketing surveillance.
@en
Safety assessment of gadobenate dimeglumine
@nl
type
label
Safety assessment of gadobenat ...... o post-marketing surveillance.
@en
Safety assessment of gadobenate dimeglumine
@nl
prefLabel
Safety assessment of gadobenat ...... o post-marketing surveillance.
@en
Safety assessment of gadobenate dimeglumine
@nl
P2093
P2860
P356
P1476
Safety assessment of gadobenat ...... o post-marketing surveillance.
@en
P2093
Kirchin MA
Pirovano G
Spinazzi A
Venetianer C
P2860
P304
P356
10.1002/JMRI.1184
P577
2001-09-01T00:00:00Z